M. Woods Wannamaker

Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2

Michael P. Clark, Mark W. Ledeboer, Ioana Davies et al. · Journal of Medicinal Chemistry · 2014 · 207 citations · Full text

Influenza Pb2, Medicinal Chemistry, Medicine +13

Zirconocene complexes of imines. General synthesis, structure, reactivity, and in situ generation to prepare geometrically pure allylic amines

Stephen L. Buchwald, Brett T. Watson, M. Woods Wannamaker et al. · Journal of the American Chemical Society · 1989 · 204 citations

Inorganic Chemistry, Chemical Engineering, Engineering +12

Discovery of VX-509 (Decernotinib): A Potent and Selective Janus Kinase 3 Inhibitor for the Treatment of Autoimmune Diseases

Luc J. Farmer, Mark W. Ledeboer, Thomas Hoock et al. · Journal of Medicinal Chemistry · 2015 · 87 citations

Immunology, Immunologic Mechanism, Janus Tyrosine Kinases +16

Synthesis of substituted pyrroles via zirconocene complexes of imines

Stephen L. Buchwald, M. Woods Wannamaker, Brett T. Watson · Journal of the American Chemical Society · 1989 · 70 citations

Inorganic Chemistry, Derivative (Chemistry), Engineering +12

Significance of the anomeric effect on the configurational stability of cyclopropyl carbanions

Albert Padwa, M. Woods Wannamaker · Tetrahedron Letters · 1986 · 54 citations

Engineering, Biochemistry, Anomeric Effect +5